Novel antigen-binding polypeptides and their uses

Details for Australian Patent Application No. 2005265163 (hide)

Owner Ambrx, Inc.

Inventors Daniel, Thomas, O.; Cujec, Thomas, P.; Kimmel, Bruce, E.; Tian, Feng; Ho, Lillian; Hays Putnam, Anna-Maria A; Cho, Ho, Sung; Wilson, Troy, E.

Agent FB Rice

Pub. Number AU-B-2005265163

PCT Pub. Number WO2006/009901

Priority 60/648,222 28.01.05 US; 60/581,334 18.06.04 US; 60/654,018 17.02.05 US

Filing date 17 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 1 October 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2006/009901 Priority application(s): WO2006/009901

7 June 2007 Corrigenda

  Amendments, Section 104 - Amendments Made Under the name Ambrx, Inc., Application No. 2005265163, under INID (72), correct the co-inventor to read Hays Putnam, Anna-Maria A

1 October 2009 Application Accepted

  Published as AU-B-2005265163

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265164-Non-natural amino acids

2005265159-Trailing beam suspension with alignment adjustment assembly